Royalty Pharma

Royalty Pharma

Buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.

Launch date
Employees
Market cap
$12.4b
Enterprise valuation
$17.5b (Public information from Sep 2024)
New York City New York (HQ)
Authorizing premium user...